Advertisement

Topics

USP Standards For Biological Drugs Would Restrict Innovation, US FDA Says

13:42 EDT 14 Jun 2019 | SCRIP

Top officials at the US FDA explain why the agency opposes USP monographs for biological products as a Senate committee...

      

Related Stories

 

Original Article: USP Standards For Biological Drugs Would Restrict Innovation, US FDA Says

NEXT ARTICLE

More From BioPortfolio on "USP Standards For Biological Drugs Would Restrict Innovation, US FDA Says"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...

Biological Therapy
Biological therapy involves the use of living organisms, substances derived from living organisms, or laboratory-produced versions of such substances to treat disease. Some biological therapies for cancer use vaccines or bacteria to stimulate the body&rs...